Litcius/Paper detail

Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)

Yoshikazu Takahashi, Yu Sunakawa, Eisuke Inoue, Ryohei Kawabata, Atsushi Ishiguro, Yosuke Kito, Yusuke Akamaru, Masazumi Takahashi, Hiroshi Yabusaki, Jin Matsuyama, Akitaka Makiyama, Masahiro Tsuda, Takahisa Suzuki, Hisateru Yasui, Ryo Matoba, Hisato Kawakami, Takako Eguchi Nakajima, Kei Muro, Wataru Ichikawa, Masashi Fujii

2021Gastric Cancer32 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNivolumabInternal medicineClinical endpointAscitesCancerGastroenterologySurgical oncologyProgression-free survivalSurvival rateClinical trialOncologyImmunotherapySurgeryOverall survivalGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersHelicobacter pylori-related gastroenterology studies
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08) | Litcius